🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsInjection technique: subcutaneous depot formation and absorption — 12 month update Page 4

Injection technique: subcutaneous depot formation and absorption — 12 month update

Dr.RenalNash Thu, Feb 8, 2024 at 9:06 AM 46 replies 2,824 viewsPage 4 of 10
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Feb 10, 2024 at 3:18 AM#16

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

9 7emma_london, tammy_FL, Dr.LipidDallas and 6 others
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Feb 10, 2024 at 7:37 AM#17

Following on from JessicaH_TX — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 10, 2024 at 12:37 PM
10 8oliver_london, tane_welly, Dr.PathRoch and 7 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Feb 10, 2024 at 11:56 AM#18
claudia_zurich said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This is where I part company with the consensus forming above. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

11 9AmyNC_wife, SkepticalSean, Dr.CardioMD and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Feb 10, 2024 at 4:15 PM#19
claudia_zurich said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

Happy to go further on any of that.

12 10Dr.PeteFamMed, claudia_zurich, nancy_portland and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 10, 2024 at 8:34 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register